Research has demonstrated that certain agents can effectively decrease UA production to mitigate liver damage associated with hyperuricemia through regulating the oxidative stress levels and the NLRP3 pathway (Ai et al., 2023). The gene discussed is NLRP3; the disease is hyperuricemia.